0001161697-21-000316.txt : 20210625 0001161697-21-000316.hdr.sgml : 20210625 20210625162516 ACCESSION NUMBER: 0001161697-21-000316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210624 FILED AS OF DATE: 20210625 DATE AS OF CHANGE: 20210625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Del Carmen Jeffrey CENTRAL INDEX KEY: 0001816477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 211048233 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 06-24-2021 X0306 4 2021-06-24 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001816477 Del Carmen Jeffrey 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Commercial Officer Common stock, par value $0.001 per share 2021-06-24 4 M 0 10000 A 10000 D Common stock, par value $0.001 per share 2021-06-24 4 F 0 2930 D 7070 D Restricted Stock Units 2021-06-24 4 M 0 10000 0 D Common Stock 10000 463334 D Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units. Derivative securities vest in equal tranches, 1/3rd on June 23, 2021, 1/3rd on June 23, 2022, and 1/3rd on June 23, 2023. Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on June 24, 2021. /s/ Jeffrey Del Carmen 2021-06-25